|
|
Current and Breaking News for Professionals, Consumers and Media |
|
|
|
|
|
|
| Current and Breaking News for Professionals, Consumers and Media |
|
|
|
|
|
Psychotherapy remains a mainstay of treatment. Various techniques can help individuals “unlearn” an addiction, resist cravings, and build a drug-free life. Options include cognitive behavioral therapy, contingency management, and a multi-pronged method called the Matrix Model. No medication is currently approved by the FDA for treating cocaine or stimulant addiction. Drugs approved for other uses may be of use, but require further research. Drugs currently under study include: · Disulfiram. Six studies show that this medication, which is approved for treating alcohol dependence, may also help reduce cocaine use. It is generally safe, but shouldn't be used by people with cardiovascular or liver problems or those with multiple mental disorders. · Baclofen. In one study, the muscle relaxant Baclofen, combined with drug abuse counseling, reduced cocaine use. · Topiramate. Two preliminary studies reported that this anticonvulsant helped volunteers avoid cocaine use or reduced cravings for it. · Modafinil. Preliminary research suggested that modafinil, a stimulant, reduced cravings for amphetamines or cocaine. Other research suggests that the drug may help delay the type of impulsive reaction that underlies addiction. Drug vaccines are designed to reduce the pleasurable effects of drug abuse and the cravings that accompany it. One anti-cocaine vaccine has reached clinical trials, and others are in development. Given the pace of drug discovery, it is unlikely any of these vaccines will reach the market soon, notes Dr. Michael Miller, editor in chief of the Harvard Mental Health Letter. In the meantime, behavioral therapies combined with medication trials offer the best hope of recovery. Also in this issue: Risks of antipsychotic treatment in children and adolescents Treating obsessive-compulsive disorder Tailoring therapy for eating disorders Depression increases pain perception The Harvard Mental Health Letter is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $59 per year. Subscribe at www.health.harvard.edu/mental www.HealthNewsDigest.com Top of Page 
|
Contact
Us | Job Listings
| Help | Site
Map | About Us
Advertising
Information | HND
Press Release | Submit
Information | Disclaimer
Site hosted by Sanchez Productions
